Hutch News
Results per Page:
ASCO 2023 highlights: Fine-tuning cancer care
Annual oncology meeting emphasizes less-toxic treatments, more precision oncology and new ways to reduce collateral damage
African Americans and the risk of reclassification in Active Surveillance
From the Lin Group, Division of Public Health Sciences
Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
What’s new in prostate cancer? 5 things to watch
Highlights from the Institute for Prostate Cancer Research 2017 community symposium
6 things men need to know about prostate cancer
Experts share their insight on screening, treatment, clinical trials and more
Investigational urine test can predict aggressive prostate cancer
Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach
Advanced prostate cancer and the age factor
Seattle Cancer Care Alliance physicians design University of Washington-based study to examine association between age at prostate-cancer diagnosis and health outcomes